Sagamore Hills, OH, United States of America

Steven Hendrix

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: National Biological Corporation. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven Hendrix. Retrieved from https://idiyas.com/inventor/steven-hendrix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Steven Hendrix

Introduction

Steven Hendrix is an accomplished inventor based in Sagamore Hills, Ohio. He holds a patent for a unique device that enhances phototherapy treatments. His innovative approach to patient care has made a significant impact in the field of therapeutic light emissions.

Latest Patents

Hendrix's notable patent is the Controlled Protocol Timer. This device is designed to provide therapeutic light emissions treatments while offering additional means for controlling a patient's exposure. The controlled protocol timer allows for incremental exposure increases, monitors patient compliance with treatment regimens, and reminds patients when their treatments are due.

Career Highlights

Steven Hendrix is currently employed at National Biological Corporation, where he contributes his expertise in developing advanced medical devices. His work focuses on improving patient outcomes through innovative technology.

Collaborations

Hendrix collaborates with talented professionals, including Kenneth Oif and Michael G. Kaufman, who share his commitment to advancing medical technology.

Conclusion

Steven Hendrix's contributions to the field of phototherapy through his Controlled Protocol Timer patent exemplify his dedication to innovation in healthcare. His work continues to influence patient treatment protocols and improve compliance in therapeutic practices.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…